Prostate cancer
-
It affects 1 in 6 men.
-
About 430,000 men in Europe are diagnosed with prostate cancer every year.
-
With early diagnosis and treatment, survival rates are greater than 90% in 5 years.
-
Thanks to the new fusion targeted biopsy technology, the diagnosis is made accurately and early.
-
Radical prostatectomy is the treatment of choice when the tumor is localized.
-
Fast recovery and return to a normal life are possible thanks to the latest advances in robotic surgery.
Robotic Radical Prostatectomy
-
Robotic radical prostatectomy is the most advanced surgical procedure for the treatment of prostate cancer and represents more than 85% of all radical prostatectomies in the United States.
-
It consists of removing the prostate and seminal vesicles. In this way, it is possible to remove all the tumor tissue.
-
Once the prostate has been removed, it is necessary to make a suture between the bladder and the urethra.
-
In some cases, a lymphadenectomy is also performed, which involves removing pelvic and abdominal lymph nodes.
-
Usually, hospital admission lasts 3 days and it is necessary to carry a bladder catheter for about 10-14 days.
-
Hundreds of patients benefit every year with the use of this technology worldwide.
Robotic surgery helps the surgeon to perform one of the most complex aspects of the intervention: conserve nerves to preserve sexual function and urinary continence
Advantages
-
Maximum precision to remove the tumor tissue
-
Rapid recovery of urinary continence
-
More patients recover their sexual function
-
Lower complication rate
-
Less pain and less pain reliever requirement
-
Less bleeding and lower transfusion rate
-
Shorter hospital stay
-
Early return to the usual routine activities.
Meet your surgeon
Dr. Carles Xavier Raventós Busquets
Dr. Raventós is a renowned urologist with a long career path in minimally invasive surgery, being a pioneer in Catalonia and Spain in several techniques for surgical treatment of prostate and bladder cancer by robotic surgery.
Doctor of Medicine and Surgery from the Autonomous University of Barcelona (UAB).
He has worked as a clinical chief at the Platon Hospital until the beginning of 2004 and is currently head of the bladder cancer unit of the Vall d’Hebron Hospital in Barcelona where he is also an associate professor at the UAB School of Medicine.